1-2 of 2
Emma Verner, FRACP,FRCPA,MBBS
Close
Save search
Sort by
Journal Articles

Autoimmune Hemolytic Anemia and Hemolytic Transfusion Reactions in Two Patients with Waldenström Macroglobulinemia Treated with Combination BTK Inhibitor and PD-1 Inhibitor

Free
Jad Othman, MBBS, Emma Verner, FRACP,FRCPA,MBBS, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Jane Huang, MD, Leo Lin, MD, James Hilger, Judith Trotman, FRACP, Robin E Gasiorowski
Journal: Blood
Blood (2017) 130 (Supplement 1): 5153.
https://doi.org/10.1182/blood.V130.Suppl_1.5153.5153
Published: 2017
Journal Articles

High Major Response Rate, Including Very Good Partial Responses (VGPR), in Patients (pts) with Waldenstrom Macroglobulinemia (WM) Treated with the Highly Specific BTK Inhibitor Bgb-3111: Expansion Phase Results from an Ongoing Phase I Study

Free
Constantine S. Tam, MBBS, Judith Trotman, MBChB, Stephen Opat, MD, Paula Marlton, MBBS, Gavin Cull, MBBS DM FRACP FRCPA, David Simpson, MBChB, FRACP, FRCPA, Matthew Ku, MBBS, David Ritchie, MD PhD, Emma Verner, FRACP, FRCPA, MBBS, Sumita Ratnasingam, MBBS, Mary Ann Anderson, MBBS, Peter Wood, MD FRACP, FRCPA, MBBS, Mark Kirschbaum, MD, Lai Wang, PhD, Ling Xue, Jianxin Yang, Eric Hedrick, John F Seymour, Andrew W. Roberts
Journal: Blood
Blood (2016) 128 (22): 1216.
https://doi.org/10.1182/blood.V128.22.1216.1216
Published: 2016